CVE-2014-8071: n/a vulnerability

CVE-2014-8071: Multiple cross-site scripting (XSS) vulnerabilities in OpenMRS 2.1 Standalone Edition allow remote attacker...

Multiple cross-site scripting (XSS) vulnerabilities in OpenMRS 2.1 Standalone Edition allow remote attackers to inject arbitrary web script or HTML via the (1) givenName, (2) familyName, (3) address1, or (4) address2 parameter to registrationapp/registerPatient.page; the (5) comment parameter to allergyui/allergy.page; the (6) w10 parameter to htmlformentryui/htmlform/enterHtmlForm/submit.action; the (7) HTTP Referer Header to login.htm; the (8) returnUrl parameter to htmlformentryui/htmlform/enterHtmlFormWithStandardUi.page or (9) coreapps/mergeVisits.page; or the (10) visitId parameter to htmlformentryui/htmlform/enterHtmlFormWithSimpleUi.page.

UnknownCVSS not scoredNot KEV-listedUpdatedAug 6, 2024, 13:10 UTC (UTC+00:00)

Security readout for executives and security teams

CVE-2014-8071 describes multiple cross-site scripting flaws in OpenMRS 2.1 Standalone Edition. An attacker could inject script or HTML through several patient registration, allergy, form, login, and visit parameters. For an exposed healthcare application, this could affect user trust, session safety, and patient workflow integrity. Exposure is most likely where OpenMRS 2.1 Standalone Edition is still deployed, especially if reachable by untrusted users or networks. The bundle does not identify broader OpenMRS versions, hosted services, or CPEs. Treat this as a targeted legacy-application risk. It is not documented as actively exploited in the provided sources, but exposed healthcare workflows with XSS can create session and data-integrity concerns. Prioritize confirmation and upgrade planning if OpenMRS 2.1 Standalone is present. Mitigation focus: Identify and retire any OpenMRS 2.1 Standalone Edition deployments.; Check OpenMRS vendor guidance for fixed versions or supported upgrade paths.; Restrict access to affected routes until remediation is confirmed..

Prepared: Jun 14, 2026, 06:22 UTC (UTC+00:00)

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cve · low confidence lookup

CVE-2014-8071 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup

Vulnerability profileCVE Program record

Severity: Unknown
CVSS: Not scored
Known Exploited: No
Published: Oct 23, 2014, 14:00 UTC (UTC+00:00)

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors

0Timeline events

0ADP providers

2Source links

CVSS and timeline data

No CVSS vectors or timeline events were available in the normalized CVE source material.

Source materials

CVE List V5 sourceCVE List V5
openmrs-cve20148071-xss(97690)CVE reference · vdb-entry, x_refsource_XF

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus

n/an/an/aListed

Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.